Hair Loss Treatment Patterns Similar Across Races

Adults with frontal fibrosing alopecia generally receive comparable care, regardless of racial background.

Updated on Oct. 29, 2026 in Beauty

Flat opaque gouache-painted illustration of a single medical instrument, representing dermatological research with a calm and muted color palette.
A retrospective study indicates that treatment patterns for frontal fibrosing alopecia remain consistent across racial backgrounds, driven primarily by secondary health conditions. AI Illustration. Upload story photo >

Live Poll

Should medical research prioritize identifying how treatment effectiveness varies by patient race?

A retrospective study presented in October 2026 found that frontal fibrosing alopecia treatment patterns are largely similar across Black and White patients. The research, which analyzed data through August 2025, noted higher usage of specific antibiotics among Black patients.

Why it matters

Understanding how treatment varies by patient demographic helps dermatologists ensure equitable care for this scarring hair loss condition. The study highlights that variations in medication choice are often driven by concurrent conditions rather than race alone.

This retrospective cohort study analyzed medical records for 142 adults, balanced between 71 Black and 71 White patients. While topical and systemic therapy rates were similar between groups, researchers observed that the higher usage of tetracycline among Black patients was tied to concurrent scarring alopecia.

The players

University of Pennsylvania Health System

An academic medical center that provided the clinical data for this study on hair loss treatments.

The details

Frontal fibrosing alopecia causes hair loss at the hairline, often requiring both topical and systemic interventions to manage inflammation and prevent further scarring. Systemic antibiotics like tetracyclines are frequently employed for their anti-inflammatory properties, particularly when multiple hair loss conditions are present. The study utilized 2-sided Fisher exact tests to compare treatment patterns, revealing that secondary diagnoses were a primary driver for specific medication choices rather than demographic differences.

Timeline

  1. Patient record review occurred from January 1, 2014, to August 22, 2025.

  2. The research findings were presented in October 2026.

Health Landscape

This study aligns with the ongoing research priorities of the Skin of Color Update, which aims to address clinical gaps in dermatology care. It builds on the broader trend of evaluating standardized treatment efficacy across diverse populations to ensure equitable health outcomes.

If you are managing frontal fibrosing alopecia, discuss your treatment plan with a dermatologist to determine if your specific hair loss pattern requires systemic therapy. Tracking any concurrent hair conditions is vital for ensuring your medication matches your individual health needs.

The takeaway

Frontal fibrosing alopecia care often includes both topical and systemic options, with specific antibiotic choices frequently linked to co-existing scarring conditions. When consulting a specialist, provide a complete history of any other hair or scalp issues to help refine your treatment approach.

Further reading

For more on managing hair health and dermatological conditions, visit our Beauty section.

Source note: This article includes information reported by Ajmc.

Live Poll

Should medical research prioritize identifying how treatment effectiveness varies by patient race?